Velindre NHS Trust   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Cardiff United Kingdom (1994)

Organization Overview

First Clinical Trial
1995
NCT00002633
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Velindre Cancer Centre Stepping Stones Appeal | Velindre NHS Trust | Velindre NHS Trust, Cardiff, UK

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Cancer Pain (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 3)

Esophageal Neoplasms (Phase 3)

Hypercalcemia (Phase 3)

Lung Neoplasms (Phase 3)

Mesothelioma (Phase 3)

Musculoskeletal Pain (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 3)

Neoplasms, Germ Cell and Embryonal (Phase 2)

Oropharyngeal Neoplasms (Phase 3)

Prostatic Neoplasms (Phase 3)

Testicular Neoplasms (Phase 2)

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 20
  • # of Trial APIs: 37